US Congress House Bill 2002 (Prior Session Legislation)

---

Spectrum: Slight Partisan Bill (Democrat 22-14)
Status: Introduced on April 21 2009 - 25% progression, died in committee
Action: 2009-04-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Medicare Patient IVIG Access Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to direct the Secretary of Health and Human Services to collect data on the differences, if any, between: (1) payments to physicians for immune globulins using average sales price payment methodology; and (2) costs incurred by physicians for furnishing these products. Requires the Secretary also to review data on the access of eligible individuals to immune globulins. Requires the Secretary, after completion of the review, to provide, if appropriate, an additional payment to such physicians for all items related to the furnishing of immune globulins as part of hospital outpatient services. Provides for Medicare coverage of and payment for intravenous immune globulin (IVIG) administered in the home. Directs the Secretary to contract for the collection of data on the practice of IVIG infusion if the Secretary determines that collection of additional data is necessary. Directs the Secretary to review data collected under such a contract as well as data submitted by members of the medical community related to the current infusion payment codes under part B (SupplementaryMedical Insurance) of SSA title XVIII. Requires the Secretary, upon completion of any data collection and review, to: (1) notify the appropriate Medicare administrative contractors regarding which existing infusion codes shall be used for purposes of part B IVIG reimbursement; or (2) report to Congress and the RBRVS Update Committee (RUC) on why an additional infusion payment code is necessary. Extends the meaning of durable medical equipment to include a disposable pump prescribed, instead of a non-disposable external infusion pump, for administration of a drug used as part of a chemotherapy regimen for treatment of colorectal cancer, if a non-disposable external infusion pump would have been covered to administer the same drug for the same indication as of July 1, 2008.

Medicare Patient IVIG Access Act of 2009

Rep. Shelley Berkley [D-NV]	Sen. Marsha Blackburn [R-TN]	Rep. Mary Bono Mack [R-CA]	Sen. John Boozman [R-AR]
Rep. Kevin Brady [R-TX]	Rep. Ginny Brown-Waite [R-FL]	Rep. Michael Burgess [R-TX]	Rep. Steve Cohen [D-TN]
Rep. Elijah Cummings [D-MD]	Rep. Theodore Deutch [D-FL]	Rep. Jim Gerlach [R-PA]	Rep. Gene Green [D-TX]
Rep. Raul Grijalva [D-AZ]	Rep. Maurice Hinchey [D-NY]	Rep. Steve Israel [D-NY]	Rep. Dale Kildee [D-MI]
Rep. Suzanne Kosmas [D-FL]	Rep. James Langevin [D-RI]	Rep. James McGovern [D-MA]	Rep. Charlie Melancon [D-LA]
Rep. Dennis Moore [D-KS]	Sen. Jerry Moran [R-KS]	Rep. Ron Paul [R-TX]	Rep. Joseph Pitts [R-PA]
Rep. David Price [D-NC]	Rep. Steven Rothman [D-NJ]	Rep. John Sarbanes [D-MD]	Rep. Mark Schauer [D-MI]
Rep. Allyson Schwartz [D-PA]	Rep. Joe Sestak [D-PA]	Rep. Lee Terry [R-NE]	Rep. Patrick Tiberi [R-OH]
Rep. Fred Upton [R-MI]	Rep. Debbie Wasserman Schultz [D-FL]	Rep. Robert Wexler [D-FL]	Rep. C.W. Young [R-FL]

Date	Chamber	Action
2009-04-22		Referred to the Subcommittee on Health.
2009-04-21		Referred to House Ways and Means
2009-04-21		Referred to House Energy and Commerce
2009-04-21		Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

SB701 (Related) 2009-03-25 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/111th-congress/house-bill/2002/all-info
Text	https://www.congress.gov/111/bills/hr2002/BILLS-111hr2002ih.pdf